Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dhanunjaya Lakkireddy, MD, FACC
• Treatments: Prednisone

Criteria

Inclusion Criteria:

1. Able to provide written informed consent;

2. Scheduled for radiofrequency ablation procedure for treatment of atrial fibrillation

Exclusion Criteria:

1. History of heart failure (right or left or biventricular) or cardiomyopathy.

2. Immunosuppressive disorders and systemic fungal infection

3. Concurrent use of corticosteroids in one week prior recruitment.

4. Allergy or prednisone or its components.

5. Other medical conditions were use of corticosteroids is not recommended or contraindicated.

6. Patients with chronic and permanent atrial fibrillation.

7. Patients with established diagnosis of rheumatological and immunological disorders.